Payment processing and merchant accounts for peptide sellers and research suppliers, with domestic and offshore options, fraud tools and recurring billing. Apply with confidence.
Peptide sellers are frequently declined or terminated, often not because the business is illegitimate but because mainstream banks group research peptides with misunderstood supplements. General processors may approve a peptide store without intending to support it, then close the account once they notice the product category, freezing funds and leaving customers unable to check out.
Daystar maintains relationships with acquiring banks that knowingly underwrite peptides and related nutraceutical merchants, alongside CBD and supplements. As a high risk merchant account provider with 20 acquiring banks across 4 continents, we have a 95% approval rate among qualified applicants, most decisions arrive within 24 hours, and most approved merchants are live within 3 business days, with no long-term contracts.
We recommend domestic or offshore processing based on your monthly volume, chargeback history and product mix. Offshore acquiring often offers higher approval odds and greater volume tolerance, while domestic accounts offer faster settlement. Both can be paired with eCheck and ACH to reduce costs, and a prior termination or MATCH listing is treated as an obstacle to work through.
Accept credit and debit cards for peptide orders online and in person, with accounts underwritten for your product category from day one so a processor does not close you after the fact. Clear billing descriptors that name your store help customers recognize charges, and accurate product labeling and site disclosures support a stable account.


Our gateways are configured for peptide businesses and integrate with online, in-store or hybrid models, including WooCommerce and custom storefronts. Encryption, AVS, CVV, 3-D Secure and velocity filters screen orders before they ship, and chargeback-alert tools let you resolve disputes before they post, helping keep ratios within acquirer limits.
Take payments at trade shows, industry events and in-person pickups with a phone or tablet. Mobile acceptance records each sale in the same reporting as your online store, and receipts go out by text or email so buyers have a record of their order. Card-present sales also carry lower dispute risk than online orders.

eCheck and ACH give customers and lab or clinic buyers a bank-funded way to pay, often at lower cost than cards on larger or wholesale orders. Pairing ACH with either a domestic or offshore card account reduces transaction costs and gives you a second rail if card processing is ever paused.

Repeat buyers can be set up on subscriptions and recurring orders with documented consent. We configure stable recurring billing with card-updater and retry tools, plus chargeback and fraud tools that keep dispute ratios acceptable. Clear terms and easy cancellation help keep recurring orders from turning into chargebacks.

Peptide suppliers often sell to customers in several countries. Multi-currency processing lets international buyers pay in their own currency, and offshore acquiring through our network of 20 acquiring banks on 4 continents supports cross-border sales. Multiple MIDs can spread volume across accounts and separate product lines or regions.

Accept credit and debit cards for peptide orders online and in person, with accounts underwritten for your product category from day one so a processor does not close you after the fact. Clear billing descriptors that name your store help customers recognize charges, and accurate product labeling and site disclosures support a stable account.
Our gateways are configured for peptide businesses and integrate with online, in-store or hybrid models, including WooCommerce and custom storefronts. Encryption, AVS, CVV, 3-D Secure and velocity filters screen orders before they ship, and chargeback-alert tools let you resolve disputes before they post, helping keep ratios within acquirer limits.
Take payments at trade shows, industry events and in-person pickups with a phone or tablet. Mobile acceptance records each sale in the same reporting as your online store, and receipts go out by text or email so buyers have a record of their order. Card-present sales also carry lower dispute risk than online orders.
eCheck and ACH give customers and lab or clinic buyers a bank-funded way to pay, often at lower cost than cards on larger or wholesale orders. Pairing ACH with either a domestic or offshore card account reduces transaction costs and gives you a second rail if card processing is ever paused.
Repeat buyers can be set up on subscriptions and recurring orders with documented consent. We configure stable recurring billing with card-updater and retry tools, plus chargeback and fraud tools that keep dispute ratios acceptable. Clear terms and easy cancellation help keep recurring orders from turning into chargebacks.
Peptide suppliers often sell to customers in several countries. Multi-currency processing lets international buyers pay in their own currency, and offshore acquiring through our network of 20 acquiring banks on 4 continents supports cross-border sales. Multiple MIDs can spread volume across accounts and separate product lines or regions.Many peptide ecommerce businesses take a large share of their orders by bank payment as well as by card. ACH and eCheck processing let customers pay straight from a checking account, which suits repeat buyers, research labs and larger orders. Banks underwrite ACH separately from cards. They look at how each debit is authorized, your expected return rates, and the same product, labeling and website disclosures they review for card processing.
Daystar works with 20 acquiring banks, so we can match a peptide seller with banks that knowingly underwrite the category for both cards and ACH, instead of a general processor that may close the account later.
We have a 95% approval rate among qualified applicants. Most decisions come within 24 hours, most approved merchants are live within 3 business days, and there are no long-term contracts.
Banks typically review your product list, labeling and website disclosures, including any research-use-only language, whether marketing makes health or therapeutic claims, age and purchase restrictions, supplier documentation, refund policy and processing history. Avoiding unsupported claims and using a clear descriptor support approval. Rules for peptides vary by jurisdiction, so confirm requirements with your counsel.
Yes. Mainstream processors typically decline peptides as high risk, but specialized acquiring banks underwrite these merchants. Approval depends on underwriting, your product mix and your website disclosures.
Often because a general processor approved them without intending to support the category, then terminated the account once it noticed the products. Placement with banks that knowingly underwrite peptides avoids that cycle.
Credit cards, debit cards, and ACH and eCheck transfers, online and in person. Multi-currency processing is supported, depending on your program.
Most decisions come within 24 hours once documentation is received, and most approved merchants are live within 3 business days. There are no long-term contracts.
A prior termination complicates approval but does not rule it out. Re-banking terminated and MATCH-listed peptide merchants is a core part of our service.
Yes. ACH and eCheck let customers pay directly from a bank account, which suits repeat and higher-value orders. Underwriters review ACH separately from cards, including how you authorize each debit and your expected return rates.
Keep product descriptions and research-use disclosures clear, use a recognizable billing descriptor, verify the customer, and respond quickly to disputes. We offer chargeback alert and fraud tools, with availability depending on your program.